|
1
|
Rini BI, Campbell SC and Escudier B: Renal
cell carcinoma. Lancet. 373:1119–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ljungberg B, Hanbury DC, Kuczyk MA,
Merseburger AS, Mulders PF, Patard JJ and Sinescu IC: European
Association of Urology Guideline Group for renal cell carcinoma:
Renal cell carcinoma guideline. Eur Urol. 51:1502–1510. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Flanigan RC, Campbell SC, Clark JI and
Picken MM: Metastatic renal cell carcinoma. Curr Treat Options
Oncol. 4:385–390. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Albiges L, Choueiri T, Escudier B, Galsky
M, George D, Hofmann F, Lam T, Motzer R, Mulders P, Porta C, et al:
A systematic review of sequencing and combinations of systemic
therapy in metastatic renal cancer. Eur Urol. 67:100–110. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Meerleer G, Khoo V, Escudier B, Joniau
S, Bossi A, Ost P, Briganti A, Fonteyne V, Van Vulpen M, Lumen N,
et al: Radiotherapy for renal-cell carcinoma. Lancet Oncol.
15:e170–e177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gao YJ, Li B, Wu XY, Cui J and Han JK:
Thyroid tumor-initiating cells: Increasing evidence and
opportunities for anticancer therapy (Review). Oncol Rep.
31:1035–1042. 2014.PubMed/NCBI
|
|
8
|
Bussolati B, Dekel B, Azzarone B and
Camussi G: Human renal cancer stem cells. Cancer Lett. 338:141–146.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang B, Huang YJ, Yao ZJ, Chen X, Guo SJ,
Mao XP, Wang DH, Chen JX and Qiu SP: Cancer stem cell-like side
population cells in clear cell renal cell carcinoma cell line 769P.
PLoS One. 8:e682932013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ueda K, Ogasawara S, Akiba J, Nakayama M,
Todoroki K, Ueda K, Sanada S, Suekane S, Noguchi M, Matsuoka K and
Yano H: Aldehyde dehydrogenase 1 identifies cells with cancer stem
cell-like properties in a human renal cell carcinoma cell line.
PLoS One. 8:e754632013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bussolati B, Bruno S, Grange C, Ferrando U
and Camussi G: Identification of a tumor-initiating stem cell
population in human renal carcinomas. FASEB J. 22:3696–3705. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhong Y, Guan K, Guo S, Zhou C, Wang D, Ma
W, Zhang Y, Li C and Zhang S: Spheres derived from the human
SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem
cells. Cancer Lett. 299:150–160. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Galleggiante V, Rutigliano M, Sallustio F,
Ribatti D, Ditonno P, Bettocchi C, Selvaggi FP, Lucarelli G and
Battaglia M: CTR2 identifies a population of cancer cells with stem
cell-like features in patients with clear cell renal cell
carcinoma. J Urol. 192:1831–1841. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lucarelli G, Galleggiante V, Rutigliano M,
Vavallo A, Ditonno P and Battaglia M: Isolation and
characterization of cancer stem cells in renal cell carcinoma.
Urologia. 82:46–53. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pajonk F, Vlashi E and McBride WH:
Radiation resistance of cancer stem cells: The 4 R's of
radiobiology revisited. Stem Cells. 28:639–648. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pastrana E, Silva-Vargas V and Doetsch F:
Eyes wide open: A critical review of sphere-formation as an assay
for stem cells. Cell Stem Cell. 8:486–498. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang P, Zhang Y, Mao L, Zhang Z and Chen
W: Side population in oral squamous cell carcinoma possesses tumor
stem cell phenotypes. Cancer Lett. 277:227–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Welte Y, Adjaye J, Lehrach HR and
Regenbrecht CR: Cancer stem cells in solid tumors: Elusive or
illusive? Cell Commun Signal. 8:62010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells-perspectives on current status and future directions:
AACR workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Golebiewska A, Brons NH, Bjerkvig R and
Niclou SP: Critical appraisal of the side population assay in stem
cell and cancer stem cell research. Cell Stem Cell. 8:136–147.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nishizawa S, Hirohashi Y, Torigoe T,
Takahashi A, Tamura Y, Mori T, Kanaseki T, Kamiguchi K, Asanuma H,
Morita R, et al: HSP DNAJB8 controls tumor-initiating ability in
renal cancer stem-like cells. Cancer Res. 72:2844–2854. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K
and Linn S: Molecular mechanisms of mammalian DNA repair and the
DNA damage checkpoints. Annu Rev Biochem. 73:39–85. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carr AM: DNA structure dependent
checkpoints as regulators of DNA repair. DNA Repair (Amst).
1:983–994. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: Models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moncharmont C, Levy A, Gilormini M,
Bertrand G, Chargari C, Alphonse G, Ardail D, Rodriguez-Lafrasse C
and Magné N: Targeting a cornerstone of radiation resistance:
Cancer stem cell. Cancer Lett. 322:139–147. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Smith J, Tho LM, Xu N and Gillespie DA:
The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and
cancer. Adv Cancer Res. 108:73–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Enomoto M, Goto H, Tomono Y, Kasahara K,
Tsujimura K, Kiyono T and Inagaki M: Novel positive feedback loop
between Cdk1 and Chk1 in the nucleus during G2/M transition. J Biol
Chem. 284:34223–34230. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou BB and Elledge SJ: The DNA damage
response: Putting checkpoints in perspective. Nature. 408:433–439.
2000. View
Article : Google Scholar : PubMed/NCBI
|
